Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06401577 · ClinicalTrials.gov registry record
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics
A clinical trial of Acute Pancreatitis, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 13
- Study locations
NCT06401577: Recruiting study of Acute Pancreatitis, sponsored by Milton S. Hershey Medical Center.
NCT06401577 is a study of Acute Pancreatitis that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 800 participants, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06401577, a study of Acute Pancreatitis, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 13
- Study locations
Study Summary
The DREAM-ON study will investigate whether continuous glucose monitoring (CGM) is useful to predict risk for developing diabetes mellitus (DM) and pre-diabetes mellitus (PDM), the need for insulin therapy among those who develop DM, and to determine whether CGM can provide insight into the pathophysiology and DM subtype among participants who have experienced an episode of acute pancreatitis (AP). Thus, the results of the DREAM-ON study could inform future clinical practice guidelines for the management AP as well as potentially extending the licensing authorization for CGM to include use in patients with pancreatogenic (Type 3c) DM.
Primary Outcome
time to onset of pre-diabetes mellitus during the 36-month longitudinal follow-up period
Conditions Studied
Interventions
- DEVICE Dexcom Continuous Glucose Monitor (CGM)
Study Locations (13)
California
- University of Southern California - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
- Stanford University - Stanford
Florida
- University of Florida - Gainesville
- AdventHealth - Orlando
Illinois
- Northwestern University - Chicago
- University of Illinois at Chicago - Chicago
Indiana
- Indiana University - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Ohio
- Ohio State University - Columbus
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2024-10-16 |
| Est. Completion | 2027-03-31 |
What NCT06401577 shows while recruiting
NCT06401577 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Acute Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Dexcom Continuous Glucose Monitor (CGM) is the first listed.
NCT06401577 lists 13 locations in 9 states (California, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT06401577 about?
NCT06401577 is a clinical study titled "Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics". The DREAM-ON study will investigate whether continuous glucose monitoring (CGM) is useful to predict risk for developing diabetes mellitus (DM) and pre-diabetes mellitus (PDM), the need for insulin therapy among those who develop DM, and to determine whether CGM can provide insight into the pathophy...
What is the current status of trial NCT06401577?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2024-10-16. Estimated completion is 2027-03-31.
What conditions does trial NCT06401577 study?
This clinical trial studies the following conditions: Acute Pancreatitis.
What interventions are being tested in trial NCT06401577?
The interventions under investigation include: Dexcom Continuous Glucose Monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT06401577?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06401577 being conducted?
This trial has 13 study locations across California, Florida, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06401577's enrollment target sits among peer trials
800 3rd of 10 higher than 7 of 10 other Acute Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
RECRUITING
-
iMmune SignAtures and Clinical outComes in AP
RECRUITING
-
Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
RECRUITING
-
Necrosectomy With Cryotechnology for Accelerated Removal
RECRUITING · NA
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
-
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI